PMID- 1584769 OWN - NLM STAT- MEDLINE DCOM- 19920616 LR - 20211203 IS - 0027-8424 (Print) IS - 1091-6490 (Electronic) IS - 0027-8424 (Linking) VI - 89 IP - 10 DP - 1992 May 15 TI - Evidence for a functional receptor for cyclosporin A on the surface of lymphocytes. PG - 4353-7 AB - Cyclosporin A (CsA) is an immunosuppressive agent that inhibits the synthesis of lymphokines by T lymphocytes at the level of transcription. A cytoplasmic protein, cyclophilin, is the most thoroughly studied CsA-binding protein, but its ubiquitous presence in cells of all types raises questions about its role in immunosuppression. In an attempt to ascertain the presence of a cell surface receptor, we synthesized two polyvalent macromolecular CsA derivatives, CsA-BBa-ovalbumin and CsA-BBa-aminodextran (CBD), from the product of the photochemical reaction of CsA and 4-benzoylbenzoic acid (CsA-BBa). (i) They inhibited the peptidylprolyl cis-trans isomerase activity of cyclophilin and the synthesis of interleukin 2 by phorbol ester-activated EL-4 cells. (ii) CBD also inhibited interleukin 2 secretion by Con A-activated T-cell-enriched mouse splenocytes. 4-Benzoylbenzoic acid (BBa)-aminodextran and aminodextran were inactive. (iii) Direct binding and competition studies with [3H]CsA indicated that CBD does not enter EL-4 cells (i.e., it acted at the surface). (iv) CBD caused agglutination of EL-4 cells, murine B and T lymphocytes, human thymocytes, and two T-cell hybridomas. Agglutination was inhibited by a monoclonal antibody to CsA and by CsA and CsA-BBa, but not by BBa. No agglutination was seen with BBa-aminodextran or aminodextran. HeLa cells, Vero (monkey kidney) cells, a mouse plasmacytoma, COS cells, and a poorly differentiated B-cell lymphoma were not agglutinated. (v) EL-4 cells failed to be agglutinated after treatment with trypsin or chymotrypsin. Specific agglutination was again possible after incubation for 5 h at 37 degrees C in the absence of enzyme. (vi) CBD covalently linked to crosslinked agarose beads inhibited interleukin 2 production by phorbol ester-stimulated EL-4 cells. No activity was seen if cell-to-bead contact was prevented by a 0.02-microns microporous filter that did not interfere with the passage of CBD. Our findings support the presence of a functional receptor on the surface of selected cells of the immune system. FAU - Cacalano, N A AU - Cacalano NA AD - Department of Microbiology, Columbia University, New York, NY 10032. FAU - Chen, B X AU - Chen BX FAU - Cleveland, W L AU - Cleveland WL FAU - Erlanger, B F AU - Erlanger BF LA - eng GR - P01-HL-36581/HL/NHLBI NIH HHS/United States GR - R01-DA-06333/DA/NIDA NIH HHS/United States GR - R01-NS-15581/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Proc Natl Acad Sci U S A JT - Proceedings of the National Academy of Sciences of the United States of America JID - 7505876 RN - 0 (Interleukin-2) RN - 0 (Receptors, Immunologic) RN - 0 (cyclosporin receptor) RN - 83HN0GTJ6D (Cyclosporine) RN - NI40JAQ945 (Tetradecanoylphorbol Acetate) SB - IM MH - Animals MH - B-Lymphocytes/metabolism MH - Cell Line MH - Cell Membrane/immunology/metabolism MH - Cyclosporine/*metabolism/pharmacology MH - Humans MH - Immunosuppression Therapy MH - Interleukin-2/metabolism MH - Kinetics MH - Lymphocytes/drug effects/*immunology/metabolism MH - Mice MH - Receptors, Immunologic/*physiology MH - T-Lymphocytes/metabolism MH - Tetradecanoylphorbol Acetate/pharmacology PMC - PMC49080 EDAT- 1992/05/15 00:00 MHDA- 1992/05/15 00:01 PMCR- 1992/11/15 CRDT- 1992/05/15 00:00 PHST- 1992/05/15 00:00 [pubmed] PHST- 1992/05/15 00:01 [medline] PHST- 1992/05/15 00:00 [entrez] PHST- 1992/11/15 00:00 [pmc-release] AID - 10.1073/pnas.89.10.4353 [doi] PST - ppublish SO - Proc Natl Acad Sci U S A. 1992 May 15;89(10):4353-7. doi: 10.1073/pnas.89.10.4353.